Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Learn how an algorithm could be used to personalize dosing schedules for IVIg.
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Learn how an algorithm could be used to personalize dosing schedules for IVIg.